| scholarly article | Q13442814 |
| P2093 | author name string | A B Federici | |
| A Girolami | |||
| Z M Ruggeri | |||
| L De Marco | |||
| A Casonato | |||
| M Mazzucato | |||
| D De Roia | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 | ||
| LIGAND: A versatile computerized approach for characterization of ligand-binding systems | Q29547346 | ||
| Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril | Q29618344 | ||
| Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent | Q33481601 | ||
| Platelets have more than one binding site for von Willebrand factor | Q33821754 | ||
| Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA. | Q33857871 | ||
| Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor | Q34366855 | ||
| Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE). | Q34528381 | ||
| Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate | Q34564820 | ||
| Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody | Q34565552 | ||
| von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia | Q34574601 | ||
| Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation | Q34624945 | ||
| Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors | Q35577294 | ||
| Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets | Q37023086 | ||
| Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets | Q37037311 | ||
| Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation | Q37554183 | ||
| Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose | Q39218339 | ||
| Generation and characterization of peptide-specific antibodies that inhibit von Willebrand factor binding to glycoprotein IIb-IIIa without interacting with other adhesive molecules. Selectivity is conferred by Pro1743 and other amino acid residues a | Q43635636 | ||
| von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib. | Q44319614 | ||
| Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimeric size | Q45884940 | ||
| Mechanism of binding of multivalent immune complexes to Fc receptors. 1. Equilibrium binding | Q52733339 | ||
| von Willebrand factor and von Willebrand disease | Q68187358 | ||
| Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa | Q68812170 | ||
| Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation | Q69117879 | ||
| The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments | Q70010199 | ||
| Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease | Q71498185 | ||
| The complex multimeric composition of factor VIII/von Willebrand factor | Q71545501 | ||
| Effect of multimeric structure of the factor VIII/von Willebrand factor protein on binding to platelets | Q71556301 | ||
| Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von willebrand factor | Q72117136 | ||
| EVIDENCE FOR LINKAGE OF UNIVALENT FRAGMENTS OR HALF-MOLECULES OF RABBIT GAMMA-GLOBULIN BY THE SAME DISULFIDE BOND | Q77065154 | ||
| The thiobarbituric acid assay of sialic acids | Q78734458 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 785-792 | |
| P577 | publication date | 1990-09-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa | |
| P478 | volume | 86 |
| Q38359108 | Conformational changes in the A1 domain of von Willebrand factor modulating the interaction with platelet glycoprotein Ibalpha |
| Q24319306 | Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations |
| Q71787422 | Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants: effects of DDAVP infusion and protease inhibitors |
| Q36925330 | Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets |
| Q34667787 | Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD. |
| Q35195297 | Germ-line mosaicism for a valine-to-methionine substitution at residue 553 in the glycoprotein Ib-binding domain of von Willebrand factor, causing type IIB von Willebrand disease |
| Q34197102 | Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit |
| Q47608817 | Hypoxia and altered platelet behavior influence von Willebrand factor multimeric composition in secondary pulmonary hypertension. |
| Q37470139 | Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib-IX receptor |
| Q52353278 | Kinetics of Free Platelet Decrease After ADP: Effect of Fibrinogen Binding Inhibitors |
| Q35612966 | O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b |
| Q63353801 | Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B platelets |
| Q37346480 | Structure and function of von Willebrand factor: relationship to von Willebrand's disease |
| Q41043544 | von Willebrand disease: pathogenesis, classification, and management |
| Q33899746 | von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure |
| Q41651628 | von Willebrand factor: biological function and molecular defects |
Search more.